已收盘 11-14 16:00:00 美东时间
+1.830
+8.83%
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
Barclays analyst Etzer Darout maintains Terns Pharma (NASDAQ:TERN) with a Overweight and raises the price target from $27 to $28.
11-11 23:34
Terns Pharmaceuticals press release (TERN): Q3 GAAP EPS of -$0.27. As of September 30, 2025, cash, cash equivalents and marketable securities were $295.6 million, as compared with $358.2 million as of...
11-11 05:55
Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.30) by 10 percent. This is a 3.57 percent increase over losses of $(0.28) per share from the same
11-11 05:43
**Terns Pharmaceuticals第三季度财务报告与企业更新** Terns Pharmaceuticals报告称,截至2025年9月30日,公司拥有2.95亿美元的现金、现金等价物和有价证券。第三季度研发费用为1990万美元,较去年同期有所上升。公司宣布其关键候选药物TERN-701在慢性髓性白血病(CML)治疗中显示出显著疗效,预计将在2025年ASH年会上展示更多数据。TERN-601在肥胖症II期试验中未达到预期效果,导致公司暂停代谢疾病项目的内部开发。此外,公司寻求合作伙伴推进TERN-501和TERN-801的开发,并专注于肿瘤学领域。
11-10 21:05
生物公司BLLN上市首周飙升66%;AI应用软件股Fastly周涨近40%,Q3财报强劲并上调营收指引;阿特斯太阳能周涨37%,公司称明年全球储能发货量同比将有明显增长>>
11-08 11:27
丹尼斯暴涨逾50%!获6.2亿美元私有化,溢价超50%;IHRT涨超37%,与奈飞商讨独家视频播客合作;赫兹租车Q3业绩超预期,大涨超36%>>
11-05 16:42
今日重点评级关注:瑞银:维持Syndax Pharmaceuticals"买入"评级,目标价从35美元升至38美元;HC Wainwright & Co.:维持Benitec Biopharma"买入"评级,目标价从28美元升至35美元
11-05 10:35
U.S. stocks were lower, with the Nasdaq Composite falling more than 350 points ...
11-05 01:37